First-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population

Autor:	A. Passioukov, Carlos Gomez-Roca, F. Ausseil, E. Garralda-Cabanas, G. Zorza, J. Besse, Julien Adam, B. Akla, S. Gautier, M. Pavlyuk, Magali Lacroix-Triki, O. Delfour, F. Cruzalegui, R. Roche, Christophe Massard
Rok vydání:	2018
Předmět:	Antibody-drug conjugate Patient population Oncology business.industry Medicine Identification (biology) Hematology First in human business Bioinformatics Class (biology)
Zdroj:	Annals of Oncology. 29:viii145-viii146
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy279.430
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::61d13e992af1060471afc6717e3075be https://doi.org/10.1093/annonc/mdy279.430 Zobrazit plný text záznamu